Drug design is a long process. Normally, it can take several years to find the perfect drug candidate to proceed with pre-clinical and clinical trials. If this time can be shortened, it would mean accelerated access to treatments for patients and saved costs in the drug development process.
If you would like to learn about the role of artificial intelligence (AI) and computer-based methods can have in academia and the pharmaceutical industry, then you should join this webinar!
Synapse – Life Science Connect is hosting an online event focusing on “Intelligent Drug Design” to explore the power of computer-based methods and AI in drug design. These tools are becoming increasingly recognised as they can lead to faster, cheaper and more efficient drug design. For those reasons, it would be extremely relevant for most life science students and young professionals to gain insight into this expanding field of opportunities for the future.
Date: Thursday, January 14, 2021
Time: 16:00 – 18:00 CET
- Ola Engkvist (Associate Director, AstraZeneca)
- Paolo Marcatili (Associate Professor, DTU)
- Emma Christine Jappe (Senior Associate, Evaxion)
- Tove Holm-Larsen (CEO, Pharma Evidence)
Participation is free but requires registration.
Please contact email@example.com for any questions regarding the event.